A study comparing 2 drugs the lignocaine spray and the EMLA cream as to which drug provides better analgesia for iv cannulation in a child

Acomparative study of 10% lignocaine spray and 2.5% lignocaine and 2.5% prilocaine (EMLA) cream to attenuate the pain on peripheral venous cannulation in children .A prospective randomised control trial at a tertiary care centre.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024385

Enrollment

100

Registered

2020-03-31

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: comparison between EMLA (2.5%LIGNOCAINE AND 2.5%PRILOCAINE) cream and 10% lignocaine spray for attenuation of pain on peripheral iv cannulation: All patients will be seen and examined a

Eligibility

Inclusion criteria

Inclusion criteria: Pediatric patients belonging to ASA 1 & 2 of age group between 7 to 17 years of either gender undergoing elective surgical procedures requiring anesthesia with no peripheral IV access will be enrolled.

Exclusion criteria

Exclusion criteria: Patients not fulfilling the inclusion criteria will be excluded,Undergoing emergency surgeries,Children with decreased level of consciousness or intellectual disabilities,those with broken skin or infection over cannulation site,children who have received analgesia or sedation in last 12 hours,adverse drug reactions to lidocaine or prilocaine,Preexisting sensory/motor deficits in the limb to be cannulated,Difficult iv cannulation,Burns

Design outcomes

Primary

Measure	Time frame
Intensity of pain will be assessed by Visual analogue scale (VAS) at the following time points Timepoint: Baseline vitals include SPO2, HR,BP a)5 mins before cannulation b)5 minutes during cannulation c)5 minutes after cannulation	—

Secondary

Measure	Time frame
Time from application to cannulation,Ease of cannulation,Number of attempts at cannulation,Incidence of adverse effects if any Timepoint: 1YEAR	—

Countries

India

Contacts

Public ContactMALAVIKA KULKARNI

MAHE-UNIVERSITY

malavika.muralidhar@gmail.com9844241620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026